Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
Chemical compound
Synthalin was an oral anti-diabetic drug. Discovered in 1926 it was marketed in Europe by Schering AG of Berlin as a synthetic drug with insulin-like properties that could be taken orally. However, it was toxic to the liver and kidney and was withdrawn from the market in the early 1940s.
Synthalin was an oral anti-diabetic drug. Discovered in 1926 it was marketed in Europe by Schering AG of Berlin as a synthetic drug with insulin-like...
compounds lowered blood glucose levels. Some less toxic derivatives, synthalin A and synthalin B, were used for diabetes treatment, but after the discovery of...
562 g·mol−1 Related compounds Related alkanamides Gusperimus Related compounds Synthalin Except where otherwise noted, data are given for materials in their standard...
studied. This result was ignored, as other guanidine analogs such as the synthalins, took over and were themselves soon overshadowed by insulin. Interest...
Flash point 113 °C (235 °F; 386 K) Related compounds Related compounds Synthalin Arginylglycylaspartic acid Gusperimus Except where otherwise noted, data...
then used to treat symptoms of diabetes. The synthetic, marketed as Synthalin, proved less toxic and more potent than prior plant products. Slotta was...
Global Information
